University of Southampton
UK Researchers ID Potential Biomarker of Response to Herceptin in Overweight Breast Cancer Patients
Premium
The study, conducted at the University of Southampton, homed in on crown-like structures of immune cells on the border of body fat and tumor tissue as a biomarker for anti-HER2 drug response.